Promis Neurosciences PMN
11.27
(0.30)
(2.59%)
as of 25 Sep
- Market cap
- $103.8M
- P/E
- 0.0×
Follow PMN
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | 10,407.27 | 30,756.82 | 159,800.00 | 0.00 | 0.00 |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | (33.50) | (32.52) | (21.15) | (29.83) | 0.00 |
P/B ratio |
— | — | — | — | — | 0.00 | 112.78 | 53.74 | 27.90 | 0.00 |
Price to Tangible BV |
— | — | — | — | — | 0.00 | 128.35 | 56.42 | 29.07 | 0.00 |
EV/Sales |
— | — | — | — | — | 10,043.86 | 29,589.73 | 153,547.67 | 0.00 | 0.00 |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | (6.80) | (7.09) | (6.91) | (7.20) | 0.00 |
EV/FCF |
— | — | — | — | — | (6.80) | (7.09) | (6.91) | (7.20) | 0.00 |
Quick Ratio |
0.59 | 6.01 | 1.35 | 0.93 | 18.31 | 0.46 | 1.06 | 1.37 | 2.79 | 0.89 |
Current Ratio |
0.88 | 8.52 | 1.46 | 1.08 | 19.07 | 0.52 | 1.21 | 1.61 | 3.31 | 1.00 |
Net Debt/EBITDA |
0.15 | 0.79 | 0.89 | 0.25 | 1.59 | 0.19 | 0.23 | 0.24 | 0.29 | 0.22 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 22.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.69 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Operating CF/Net income |
0.71 | (9.78) | 0.82 | 0.94 | 0.95 | 0.77 | 0.82 | 0.85 | 0.95 | 0.74 |
Capex/Depreciation |
— | — | 0.00 | (0.18) | 2.02 | (6.93) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (521.61%) | 27.46% | (1,098.52%) | (837.71%) | (399.46%) | 1,844.24% | (935.12%) | (756.07%) | (751.91%) | 0.00% | |
| (282.76%) | 17.08% | (128.63%) | (146.42%) | (104.26%) | (325.59%) | (289.47%) | (395.87%) | (386.10%) | 0.00% | |
ROIC |
0.00% | (332.40%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
3,230.78% | 16.65% | (309.46%) | (3,680.18%) | (58.31%) | 533.91% | (2,114.49%) | (923.14%) | (409.00%) | (326,150.00%) |
Average Days of Receivables |
— | — | — | 0.00 | 0.00 | 8,310.77 | 22,670.56 | 38,507.50 | 1,709.74 | 6,387.50 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 182,784.62% | 396,500.00% | 1,429,125.00% | 40,207.89% | 70,440.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 142,469.23% | 222,911.11% | 531,950.00% | 20,923.68% | 59,520.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.03 | 0.07 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 15,038.46% | 54,211.11% | 207,325.00% | 7,047.37% | 21,585.00% |
Graham Net Nets |
— | — | — | — | — | (0.04) | 0.01 | 0.02 | 0.03 | 0.00 |
Graham Number |
— | — | — | — | — | 44.51 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | (18.46%) | (16.47%) | (16.30%) | (14.08%) | (14.08%) |
Free Cash Flow Yield |
— | — | — | — | — | (14.20%) | (13.56%) | (13.91%) | (13.32%) | 0.00% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.06 | 0.02 |
Operating CF per Share |
(16.00) | (26.21) | (22.05) | (56.76) | (40.21) | (17.04) | (26.45) | (41.73) | (31.97) | (16.93) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | 0.40 | (0.43) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(16.00) | (26.21) | (22.05) | (56.77) | (39.81) | (17.46) | (26.45) | (41.73) | (31.97) | (16.93) |
Cash per Share |
3.50 | 12.85 | 25.69 | 19.68 | 73.37 | 4.19 | 7.40 | 11.74 | 9.71 | 5.01 |
Shareholders Equity per Share |
(0.72) | 15.90 | 7.63 | (4.49) | 24.46 | (3.97) | 1.73 | 5.58 | 8.60 | 0.46 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.72) | 15.90 | 7.63 | (4.49) | 24.46 | (3.97) | 1.73 | 5.58 | 8.60 | 0.46 |
Free Cash Flow |
(28.12) | (27.18) | (10.84) | (17.04) | (9.21) | (3.33) | (4.59) | (6.67) | (4.40) | (1.92) |
Working Capital |
(1.23) | 16.69 | 4.27 | 0.49 | 16.79 | (0.87) | 0.26 | 0.85 | 1.13 | 0.00 |
Capital Expenditures |
— | — | — | 0.00 | 0.09 | (0.08) | — | — | — | — |
Net Current Asset Value |
(1.26) | 16.49 | 3.75 | (1.37) | 5.63 | (0.87) | 0.26 | 0.85 | 1.13 | 0.00 |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 0.00 | 0.00 | 62.38 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (325,153.85%) | (619,311.11%) | (1,960,975.00%) | (61,102.63%) | (130,460.00%) |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
— | — | 0.00 | 37.33 | 9.74 | 0.16 | 0.00 | 3.40 | 3.40 | 3.57 |
Cash ROIC |
(574.82%) | (91.18%) | (66.19%) | (373.64%) | (35.08%) | (8,090.51%) | (289.76%) | (240.99%) | (174.65%) | (309.43%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 0.00 | 0.03 | 0.02 | 0.01 | 0.22 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
— | — | — | 0.05 | 0.03 | 0.04 | 0.05 | 0.04 | 0.04 | — |
Average Payables |
2.14 | 4.79 | 5.41 | 1.69 | 0.41 | 0.76 | 0.83 | 0.38 | 0.39 | — |
Average Assets |
14.05 | 16.27 | 10.27 | 12.34 | 9.39 | 1.30 | 1.93 | 1.98 | 1.20 | — |
Average Common Equity |
7.61 | 10.12 | 1.20 | 2.16 | 2.45 | (0.23) | 0.60 | 1.04 | 0.62 | — |
Columns are period end dates